AEON Biopharma (AEON) Stock Price
AEON Biopharma Price
AEON Biopharma's net margin stands at -1,307.1%, down from 5,151.0% several years earlier.
AEON Biopharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
AEON Biopharma business model & stock analysis
Frequently asked questions about AEON Biopharma
10 analysts currently rate the AEON Biopharma stock: 9 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the AEON Biopharma share trades at 0.21 EUR (0.24 USD).
The revenue cannot currently be calculated for AEON Biopharma.
The expected profit of AEON Biopharma is -234,802.13 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of AEON Biopharma is currently -12.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the AEON Biopharma stock.
The P/S cannot be calculated for AEON Biopharma currently.
The Eulerpool Quality Score for AEON Biopharma is 1/10.
The ISIN of AEON Biopharma is US00775E1029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of AEON Biopharma is AEON. The ticker symbol is used to trade AEON Biopharma shares on the stock exchange.
AEON Biopharma stock
AEON Biopharma Peer Group
All fundamentals and in-depth analysis of AEON Biopharma
Our stock analysis for AEON Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AEON Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.